View from the Thoraxcenter: What’s Hot at ESC 25?

Expert interventionalists, Prof Nicolas Van Mieghem and Dr Joost Daemen (Thoraxcenter, Erasmus MC, Rotterdam, NL) discuss the most anticipated hot line studies to be unveiled at ESC Congress 2025. Tune in for their in-depth analysis to get ahead of the curve. ESC Congress 2025 Hot Line Trials Discussed: 00:25 - DOUBLE-CHOICE 03:03 - VANTAGE 05:03 - VICTOR 06:28 - VICTORIA 07:58 - DIGIT HF 10:19 DAPA ACT HF-TIMI 68 12:35 REBOOT-CNIC 14:07 BETAMI DANBLOCK 16:03 REFINE ICD 18:05 OPTION STEMI 20:43 DUAL ACS 22:46 NEO MINDSET 24:53 TARGET FIRST 26:59 OUTREACH 29:29 FIRE 31:40 AI GATEKEEPER 22:42 LAA CLOSURE Stay tuned for Radcliffe Cardiology’s in-depth coverage of these and other pivotal trials from ESC Congress 2025.